When analyzing two independent, CMS classified colon cancer patient cohorts (TCGA-COAD [46] and Marisa et al. (2013) [29]), we found highest LARGE2 mRNA levels in CMS2, specified by an active WNT/MYC program [31] (Fig. 2A,B). This evidence concerns the gene MYC and colonic neoplasm.